Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

Know-how & network

experience — strong global network
science – industry – finance

To foster the development of each company, GLSV commits itself to transferring the expertise of its team to its portfolio companies. This may include the conveying of know-how in areas as diverse as molecular biology, immunology, diagnostics and medical devices to marketing, senior level strategic business development, finance and administration. This transfer of know-how reflects the commitment of GLSV to the long-term growth of its portfolio companies.

GLSV has access to a strong network of scientific, industrial and financial professionals from prestigious institutions. They are available to provide specific advice that may be critical to the success of a company at different stages of its development.